Amy Elazzouzi - Oct 29, 2024 Form 4 Insider Report for Aura Biosciences, Inc. (AURA)

Role: Vice President, Finance
Signature: /s/ Conor Kilroy, as Attorney-in-Fact
Stock symbol: AURA
Transactions as of: Oct 29, 2024
Transactions value $: -$5,938
Form type: 4
Date filed: 10/29/2024, 08:23 PM
Previous filing: Oct 29, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AURA	Common Stock	Sale	-$5.94K	-553	-1.38%	$10.74	39.4K	Oct 29, 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
F2	The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.65 to $10.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.65 to $10.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.